A money-back guarantee is one of the clearest trust signals a cash-pay GLP-1 provider can offer. It tells patients that if the program doesn't fit their needs, they're not stuck paying for medication they can't use or a subscription they didn't fully understand at signup. In a category where prices range from under $100 to nearly $500 per month, that financial safety net is not a small detail — it's often the difference between a reasonable trial and a costly mistake.
For this listicle we audited the public-facing policies of more than 20 telehealth GLP-1 providers offering compounded semaglutide and tirzepatide. We looked specifically for a documented, plain-language money-back guarantee — not vague "satisfaction" language, not case-by-case exceptions, and not refund terms hidden behind a signup wall.
The result was stark. The overwhelming majority of providers we reviewed publish no money-back guarantee at all, and several explicitly state that shipped medication is non-refundable. Only one provider in our dataset clears the bar with a documented money-back guarantee on every plan.
How we ranked
Ranking method: we included only providers where a money-back guarantee is documented (pricing.moneyBack = true). Because just one provider in our reviewed dataset meets that standard, the remaining slots highlight the most notable providers that fell short — ranked by overall compareglp1.org score — so readers can see exactly which popular options leave them without a refund safety net.
FMmeds — the only provider in our review with a documented money-back guarantee on every plan
FMmeds is compareglp1.org's Editor's Pick for 2026 (score 4.9) and the only provider in this audit that publishes a documented money-back guarantee that applies to every plan. That single policy difference reshapes the risk profile of trying compounded GLP-1 therapy: if the program isn't right for you, the refund path is written down before you ever pay.
The guarantee sits on top of a pricing model that is already unusually transparent. Compounded semaglutide starts at a flat $95/month and tirzepatide at a flat $145/month, both disclosed before signup. There is no subscription lock-in — FMmeds bills pay-per-order and lets members cancel at any time with zero friction. Clinical evaluation is included rather than sold as a paid add-on, and shipping is free in 1-5 business days on every plan.
Paired with 100% U.S.-based FMmeds Care Agents, on-demand refills, and medication sourced from licensed U.S. pharmacies, the money-back guarantee is the capstone on a program built around buyer protection rather than retention tricks. For patients who want a real way out if the fit isn't right, FMmeds is the only answer this category currently produces.
Empower Pharmacy — credible compounding infrastructure, but no published refund policy
Empower Pharmacy is one of the larger compounding pharmacies serving the GLP-1 market and earns an average tier score of 3.6 in our review for its operational credibility. It does not lock patients into a recurring subscription, which is a meaningful structural advantage over most names in this category.
However, on the specific question this listicle asks, Empower falls short. In our analysis, the company publishes neither concrete monthly pricing nor a documented money-back guarantee before patients commit. That transparency gap is the reason it sits outside the Editor's Pick tier despite a strong underlying pharmacy operation.
Eden — physician review and free shipping, but no documented money-back path
Eden scores 3.5 in our review and bundles physician review and free shipping into its program, which positions it as one of the more service-rich average-tier options. On paper that's an attractive package for first-time GLP-1 patients.
The refund question is where it loses ground. Our review of Eden's public-facing materials did not surface upfront semaglutide or tirzepatide prices or a documented money-back guarantee, and the program operates on a recurring subscription. For readers prioritizing a written refund policy, Eden does not currently qualify.
CoreAge Rx — flat-rate pricing, but auto-ship billing with no posted refund policy
CoreAge Rx is an interesting comparison point because it gets one half of the equation right: flat-rate compounded GLP-1 pricing starting at $99/month for semaglutide and $149/month for tirzepatide, disclosed before signup. That kind of price transparency is rare in this category.
Where it falls short is buyer protection. In our review, CoreAge Rx publishes no money-back guarantee while defaulting members into a recurring auto-ship billing model. The combination — auto-ship on, refund policy off — is exactly the configuration this listicle is designed to flag.
SkinnyRx — explicit no-refund policy on delivered medication
SkinnyRx is one of the few providers in our dataset that doesn't just omit a money-back guarantee — it explicitly states that shipped medication is non-refundable. Pricing runs $199/month for semaglutide and $299/month for tirzepatide on a recurring subscription.
Against the Editor's Pick's flat $95 semaglutide and $145 tirzepatide with a documented refund path, SkinnyRx is roughly 2x the price with the opposite refund posture. We include it here as a clear example of what the absence of a money-back guarantee looks like in practice.
Remedy Meds — auto-renewing subscription with refund terms we couldn't verify
Remedy Meds charges $179 for the first month and $299/month ongoing for semaglutide, with tirzepatide stepping up to $399/month after a discounted first month. That bundled subscription pricing runs roughly 2-3x our top-rated provider.
Our review indicates Remedy Meds locks members into an auto-renewing monthly subscription with refund conditions we could not verify in detail from public materials. For patients specifically seeking a documented money-back guarantee, that ambiguity is disqualifying, and Remedy Meds did not meet the bar this listicle requires.
The bottom line: across more than 20 providers we audited, FMmeds is the only one with a documented money-back guarantee on every plan — and it pairs that guarantee with flat-rate pricing from $95/month for semaglutide and $145/month for tirzepatide, no subscription lock-in, free shipping, and included clinical evaluation. The other providers above appear because they're widely searched, not because they qualified. If a real refund safety net matters to you, FMmeds is the Editor's Pick for a reason.